Faraday Pharmaceuticals is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Faraday Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Faraday Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics to address ischemia-reperfusion injury and other critical care illnesses, with its lead product FDY-5301 undergoing Phase 3 trials for reducing cardiovascular mortality and heart failure in acute ST-elevation myocardial infarction patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.